Researchers from Children's Hospital of Philadelphia (CHOP) and Stanford University have revealed the molecular structure of TRACeR-I, a protein platform for reprogramming immune responses. A better ...

UB researchers have published the first longitudinal studies of paramagnetic rim lesions, an indicator of brain inflammation in MS.

Briumvi (ublituximab) has been approved by NICE (National Institute for Health and Care Excellence) for people with active relapsing remitting multiple sclerosis. In England and Wales, NICE has ...

Researchers founded Rarity PBC as a public benefit corporation that will license the IP and develop operations to potentially ...

AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced interim safety and tolerability data from the ...

Autoimmune diseases affect millions of people worldwide, often in ways that can be life-altering. These conditions occur when ...

Immune checkpoint inhibitors may heighten cardiovascular risks by altering immune interactions in atherosclerotic plaques, ...

Synthetic biology techniques have emerged as transformative tools in the tug-of-war between humans and drug-resistant ...

1. The use of rituximab, abatacept and Janus kinase inhibitors (JAKis) in individuals with rheumatoid arthritis (RA) was associated with a statistically significant higher risk of cancer incidence ...

Copyright: © 2024 Published by Elsevier Ltd. We read with great interest the thoughtful and well balanced Editorial on the regulatory decisions regarding lecanemab ...

These medicines aim to: Control the growth of the virus Improve how well your immune system works Slow or stop symptoms Prevent transmission of HIV to others By taking your HIV medications ...